Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial.

MLA

Kyle, Simon D., et al. “Clinical and Cost-Effectiveness of Nurse-Delivered Sleep Restriction Therapy for Insomnia in Primary Care (HABIT): A Pragmatic, Superiority, Open-Label, Randomised Controlled Trial.” Lancet (London, England), vol. 402, no. 10406, Sept. 2023, pp. 975–87. EBSCOhost, https://doi.org/10.1016/S0140-6736(23)00683-9.

APA

Kyle, S. D., Siriwardena, A. N., Espie, C. A., Yang, Y., Petrou, S., Ogburn, E., Begum, N., Maurer, L. F., Robinson, B., Gardner, C., Lee, V., Armstrong, S., Pattinson, J., Mort, S., Temple, E., Harris, V., Yu, L.-M., Bower, P., & Aveyard, P. (2023). Clinical and cost-effectiveness of nurse-delivered sleep restriction therapy for insomnia in primary care (HABIT): a pragmatic, superiority, open-label, randomised controlled trial. Lancet (London, England), 402(10406), 975–987. https://doi.org/10.1016/S0140-6736(23)00683-9

Chicago

Kyle, Simon D, A Niroshan Siriwardena, Colin A Espie, Yaling Yang, Stavros Petrou, Emma Ogburn, Nargis Begum, et al. 2023. “Clinical and Cost-Effectiveness of Nurse-Delivered Sleep Restriction Therapy for Insomnia in Primary Care (HABIT): A Pragmatic, Superiority, Open-Label, Randomised Controlled Trial.” Lancet (London, England) 402 (10406): 975–87. doi:10.1016/S0140-6736(23)00683-9.